These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1309798

  • 1. Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.
    Torphy TJ, Stadel JM, Burman M, Cieslinski LB, McLaughlin MM, White JR, Livi GP.
    J Biol Chem; 1992 Jan 25; 267(3):1798-804. PubMed ID: 1309798
    [Abstract] [Full Text] [Related]

  • 2. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA.
    McLaughlin MM, Cieslinski LB, Burman M, Torphy TJ, Livi GP.
    J Biol Chem; 1993 Mar 25; 268(9):6470-6. PubMed ID: 8384210
    [Abstract] [Full Text] [Related]

  • 3. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
    Wilson M, Sullivan M, Brown N, Houslay MD.
    Biochem J; 1994 Dec 01; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
    Jacobitz S, McLaughlin MM, Livi GP, Burman M, Torphy TJ.
    Mol Pharmacol; 1996 Oct 01; 50(4):891-9. PubMed ID: 8863835
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ, Zhou HL, Cieslinski LB.
    J Pharmacol Exp Ther; 1992 Dec 01; 263(3):1195-205. PubMed ID: 1335058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
    Souness JE, Scott LC.
    Biochem J; 1993 Apr 15; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
    [Abstract] [Full Text] [Related]

  • 10. Dual inhibition of human type 4 phosphodiesterase isostates by (R, R)-(+/-)-methyl 3-acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate.
    Tian G, Rocque WJ, Wiseman JS, Thompson IZ, Holmes WD, Domanico PL, Stafford JA, Feldman PL, Luther MA.
    Biochemistry; 1998 May 12; 37(19):6894-904. PubMed ID: 9578576
    [Abstract] [Full Text] [Related]

  • 11. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding.
    Rocque WJ, Holmes WD, Patel IR, Dougherty RW, Ittoop O, Overton L, Hoffman CR, Wisely GB, Willard DH, Luther MA.
    Protein Expr Purif; 1997 Mar 12; 9(2):191-202. PubMed ID: 9056484
    [Abstract] [Full Text] [Related]

  • 12. CDP840: a novel inhibitor of PDE-4.
    Perry MJ, O'Connell J, Walker C, Crabbe T, Baldock D, Russell A, Lumb S, Huang Z, Howat D, Allen R, Merriman M, Walls J, Daniel T, Hughes B, Laliberte F, Higgs GA, Owens RJ.
    Cell Biochem Biophys; 1998 Mar 12; 29(1-2):113-32. PubMed ID: 9631241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret.
    Duplantier AJ, Biggers MS, Chambers RJ, Cheng JB, Cooper K, Damon DB, Eggler JF, Kraus KG, Marfat A, Masamune H, Pillar JS, Shirley JT, Umland JP, Watson JW.
    J Med Chem; 1996 Jan 05; 39(1):120-5. PubMed ID: 8568798
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE, Hassall GA, Parrott DP.
    Biochem Pharmacol; 1992 Sep 01; 44(5):857-66. PubMed ID: 1326964
    [Abstract] [Full Text] [Related]

  • 16. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
    Owens RJ, Catterall C, Batty D, Jappy J, Russell A, Smith B, O'Connell J, Perry MJ.
    Biochem J; 1997 Aug 15; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
    [Abstract] [Full Text] [Related]

  • 17. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE, Diocee BK, Martin W, Moodie SA.
    Biochem J; 1990 Feb 15; 266(1):127-32. PubMed ID: 2155604
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities.
    Rocque WJ, Tian G, Wiseman JS, Holmes WD, Zajac-Thompson I, Willard DH, Patel IR, Wisely GB, Clay WC, Kadwell SH, Hoffman CR, Luther MA.
    Biochemistry; 1997 Nov 18; 36(46):14250-61. PubMed ID: 9369498
    [Abstract] [Full Text] [Related]

  • 20. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1998 May 18; 124(1):129-40. PubMed ID: 9630352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.